| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |